Quidel Corp (NASDAQ:QDEL)

56.02
Delayed Data
As of 11:27am ET
 +0.39 / +0.70%
Today’s Change
44.27
Today|||52-Week Range
77.63
+14.75%
Year-to-Date
Masimo Gets FDA Nod for Radius PPG, Boosts Patient Monitoring
9:46am / Zacks.comZAK - Paid Partner Content
QDEL vs. GNNDY: Which Stock Is the Better Value Option?
May 13 / Zacks.com - Paid Partner Content
Here's Why You Should Retain Cooper Companies (COO) Stock
May 20 / Zacks.comZAK - Paid Partner Content
Quidel (QDEL) Q1 2019 Earnings Call Transcript
May 09 / MotleyFool.com - Paid Partner Content
Here's Why You Should Retain DaVita (DVA) in Your Portfolio
May 16 / Zacks.comZAK - Paid Partner Content
Quidel (QDEL) Misses Q1 Earnings and Revenue Estimates
May 08 / Zacks.com - Paid Partner Content
Here's Why You Should Hold on to PerkinElmer (PKI) Stock Now
May 14 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close55.63
Today’s open55.91
Day’s range55.69 - 56.45
Volume37,574
Average volume (3 months)220,961
Market cap$2.2B
Data as of 11:27am ET, 05/21/2019

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-0.40%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)+88.05%
P/E ratio35.1
Price/Sales3.98
Price/Book5.19

Competitors

 Today’s
change
Today’s
% change
--Quidel Corp-0.36-0.72%
MYGNMyriad Genetics Inc+0.27+1.07%
IMMUImmunomedics Inc+0.53+3.40%
NEOGNeogen Corp+0.53+0.91%
Data as of 11:42am ET, 05/21/2019

Financials

Next reporting dateAugust 6, 2019
EPS forecast (this quarter)$0.16
Annual revenue (last year)$522.3M
Annual profit (last year)$74.2M
Net profit margin14.20%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Douglas C. Bryant
Senior VP-
International Commercial Operations
Ratan S. Borkar
Corporate headquarters
San Diego, California

Forecasts